General Trading Chat

vijkris

Learner and Follower
Infosys results show IT hiring in slow lane

At first glance, Infosys’s latest quarterly numbers look uninspiring. Many feel that the company’s best days are behind, and that it no longer deserves the label of a growth stock.

In the post earnings conference call with analysts and fund managers, the management didn’t sound too bullish. So do not expect a return to the Murthy era of under promise and over deliver.

CEO Vishal Sikka said that the company would stay the course on transformation, but requested investors to be patient as radical changes, including those in organisational culture, would take time.

Still, it may be too early to write off the erstwhile industry bellwether as it tries to navigate the ongoing disruption in the sector.

A few takeaways from the call that captured our attention:

Beginning Q1 FY18, Infosys will start reporting the revenue from emerging technologies like AI (artificial intelligence), digital and cloud services (Skava, Mana, Panaya and Edge in Infosys parlance) separately. According to the management these businesses have grown 43 percent in FY17.

It expects wage hikes (mid to high single-digit wage growth) and visa costs to be a drag on June quarter earnings, but is hopeful of a better performance in the second half of the fiscal.

The management reiterated that it does not want to remain a commoditised provider of IT services. AI is having a strong impact on its traditional portfolio and the company sees opportunity in AI in the coming years.

Currently, 65 percent of the Infosys workforce is contributing to 55 percent of the revenue (mostly traditional services that are growing slowly) and the average revenue per employee is around USD 48,000. Around 35 percent of the employees are contributing to 45 percent of the revenue (this piece is growing at a rate of 20 percent) and are therefore reporting a much higher revenue per employee at USD 72,000.

While not explicitly admitting that AI is eliminating jobs rapidly, Sikka said the company needed more of highly skilled workers. The numbers speak for themselves, nevertheless. Infosys added 6,320 people to the work force which is down 65 percent from last year’s addition of 17,857. This is indeed a wake-up call for our engineering colleges, coaching centres and the aspiring IT professionals. In fact, as an adjunct the company also mentioned that attrition including that of the high performers have been stable.

On the contentious issue of US Visa, while admitting that there remains considerable uncertainty, the management nevertheless alluded to the steps taken like onsite development centre in the US to step up local hiring and training. They however, haven’t seen any undue delay in visa processing so far.

What to do with the stock?

The disappointing numbers coupled with the subdued guidance has taken the expected toll on the stock price, with the scrip down 4 percent. We do not rule out short-term weakness on the back of earnings downgrade. However, the valuation at 14.4 times FY18 estimated earnings isn’t too demanding when seen in the context of healthy dividend yield and probable upside from currency movement. Hence, for investors who are looking for steady cash flow of dividend as opposed to the excitement of capital appreciation of a growth stock, it might be worth accumulating the declines.
http://www.moneycontrol.com/news/business/infosys-results-show-it-hiring-on-a-slow-lane-2258265.html
 
On valuable lesson for me on social site like TJ……………
when people ask something using the word “pls” they really don’t mean it they just use the word “pls” as tactics to get the thing from you……… disgusting:mad:.
if moderator want they can delete the post ……….. their choice.
kisi ne kaat diya kya...:lol:
 

vijkris

Learner and Follower
News for those who are interested in Pharma Sector:

USFDA issues warning letter to Mylan for Nashik facility

The US health regulator has issued a warning letter to drug firm Mylan for violations of good manufacturing norms, including data integrity lapses and failure of quality control at its Nashik facility.

The letter by the United States Food and Drug Administration (USFDA) to the Mylan Pharmaceuticals Inc President Rajiv Malik states that it had inspected the Nashik facility of the company from September 5 to 14, 2016.

There were "significant violations of current good manufacturing practice (CGMP) regulations for finished pharmaceuticals", at the facility, it added.

During the inspection, the FDA investigator observed specific violations such as the quality system not fully ensuring data integrity, the regulator said. "Your quality system does not adequately ensure the accuracy and integrity of data to support the safety, effectiveness and quality of the drugs you manufacture," the letter said.

While acknowledging that company is using a consultant to audit the operation and assist in meeting FDA requirements the USFDA asked to provide "a comprehensive investigation into the extent of the inaccuracies in data records and reporting".

The letter also asked the drug firm to provide a current risk assessment of the potential effects of the observed failures on the quality of the drugs and a management strategy "that includes the details of your global corrective action and preventive action plan".

The FDA said it has reviewed company's October 5, 2016, response in detail and also acknowledged receipt of its subsequent correspondence. Other violation was that, "Your firm failed to thoroughly investigate any unexplained discrepancy or failure of a batch or any of its components to meet any of its specifications, whether or not the batch has already been distributed", the letter said.

The pharma firm also failed to establish an adequate quality control unit with the authority to review production records to assure that no errors have occurred or, if errors have occurred, that they have been fully investigated, it added.

"Until you correct all violations completely and we confirm your compliance with CGMP, FDA may withhold approval of any new applications or supplements listing your firm as a drug manufacturer," the warning letter said.

Failure to correct these violations may also result in FDA refusing admission of articles manufactured at Mylan Laboratories at the Nashik plant, it added.
http://www.moneycontrol.com/news/bu...ter-to-mylan-for-nashik-facility-2258345.html
 

vijkris

Learner and Follower
Answered: All your questions about the daily revision of petrol, diesel prices

Petrol and diesel prices are soon going to be revised every day, in sync with international market rates.

You've probably been hearing a lot about the government's plan to revise petrol and diesel prices on a daily basis. But how does it affect you? Here's an overview:

What exactly is happening?

Petrol and diesel prices are soon going to be revised every day, in sync with international market rates. There has been talk of a daily price change for a long time, but the technology has only now been made available to state-run oil firms.

How often are petrol and diesel rates currently changed in India?

State fuel retailers currently revise rates on 1st and 16th of every month based on average international price of the fuel in the preceding fortnight.

Who is going to carry out this exercise?

State-owned fuel retailers Indian Oil Corp (IOC), Bharat Petroleum Corp Ltd (BPCL) and Hindustan Petroleum Corp Ltd (HPCL), which own over 95 percent of nearly 58,000 petrol pumps in the country.

When does the daily price revision begin?

May 1.

Where will it be implemented?

To begin with, daily revision of fuel prices will be implemented in Puducherry and Vizag in southern India, Udaipur in the West, Jamshedpur in the East and Chandigarh in the North.

What about the rest of the country?

Oil PSUs will initially launch a pilot for daily price revision in only the above mentioned five cities and gradually extend it to all over the country.

Why does it matter?

A shift to daily revision would mean that prices don't drop or rise sharply, as rates may only change by a few paise everyday and will not lead to a price shock for customers. It may also help the government avoid any political backlash as incremental price changes may go mostly unnoticed.

Is India ready?

With modern means of communication like social media available, communicating price revisions to petrol pumps may not be a problem.

However, the Petroleum Dealers Association has expressed concerns over back-end infrastructure at retail outlets to implement such a system. They have requested that the transition happen in a phased manner.
http://www.moneycontrol.com/news/bu...revision-of-petrol-diesel-prices-2257623.html
 
holding good amt of CEs .. need a rally on monday ..:down::down:
 

rip07

Well-Known Member
You will not make money long term until you know enough about your
personality to find a trading style that is compatible. You need to be
able to follow your rules comfortably, allowing you to enter and exit
trades with minimal or no uncertainty or anxiety. Once you have mastered
a method of trading, if you feel stress while trading, then either
you haven't yet found your style or yourself---Al Brooks

Thanks
rip07
 
You will not make money long term until you know enough about your
personality to find a trading style that is compatible. You need to be
able to follow your rules comfortably, allowing you to enter and exit
trades with minimal or no uncertainty or anxiety. Once you have mastered
a method of trading, if you feel stress while trading, then either
you haven't yet found your style or yourself---Al Brooks

Thanks
rip07
Very True...:thumb:
 

Similar threads